Pr. Frédéric LIRUSSI, professor-hospital practitioner (PU-PH, Pharm D, PhD), is the head of the team. He studied the contribution of inflammation and oxidative stress in parturition related disorders. He focused his research on phagocytes (macrophages and neutrophils) and identified a new receptor (β3-AR) that regulates inflammation and polarizes macrophages toward a tolerogenic M2-like phenotype, using a translational approach. During these years he got an expertise in organotypic culture and co-culture of human primary cell lines. In 2012, he extended his work on inflammatory bowel diseases, by joining the team headed by Carmen GARRIDO. Since macrophage regulation plays a key role in IBD, as it does in parturition, he transposed his knowledge on β3-AR induced macrophage regulation from pregnancy to intestinal diseases. In parallel with in vitro studies, he has also conducted human biomarkers studies (PHENOMAP & ICAR) as principal investigator in collaboration with INSERM CIC 1432.
Pr. Frédéric LIRUSSI, professor-hospital practitioner (PU-PH, Pharm D, PhD), is the head of the team. He studied the contribution of inflammation and oxidative stress in parturition related disorders. He focused his research on phagocytes (macrophages and neutrophils) and identified a new receptor (β3-AR) that regulates inflammation and polarizes macrophages toward a tolerogenic M2-like phenotype, using a translational approach. During these years he got an expertise in organotypic culture and co-culture of human primary cell lines. In 2012, he extended his work on inflammatory bowel diseases, by joining the team headed by Carmen GARRIDO. Since macrophage regulation plays a key role in IBD, as it does in parturition, he transposed his knowledge on β3-AR induced macrophage regulation from pregnancy to intestinal diseases. In parallel with in vitro studies, he has also conducted human biomarkers studies (PHENOMAP & ICAR) as principal investigator in collaboration with INSERM CIC 1432.